Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Vittoria Resi"'
Autor:
Laura Bonanno, Paola Del Bianco, Valentina Guarneri, Fiorella Calabrese, Antonio Rosato, Anna Tosi, Martina Lorenzi, Anna Roma, Alberto Pavan, Antonio Scapinello, Maria Vittoria Resi, Stefano Frega, Giulia Pasello
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Purpose Small-cell lung cancer (SCLC) is an aggressive disease with a dismal prognosis. The addition of immune checkpoints inhibitors to standard platinum-based chemotherapy in first-line setting achieves a durable benefit only in a patient subgroup.
Externí odkaz:
https://doaj.org/article/905ba62164a94761bf5829ce84a3adb3
Autor:
Martina Lorenzi, Maria Vittoria Resi, Laura Bonanno, Stefano Frega, Alessandro Dal Maso, Alessandra Ferro, Valentina Guarneri, Giulia Pasello
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Extensive stage-Small-Cell Lung Cancer (ES-SCLC) is an aggressive cancer with dismal prognosis. The addition of immune-checkpoint inhibitors (ICIs) to platinum-based chemotherapy have been consistently demonstrated to improve outcomes and survival, b
Externí odkaz:
https://doaj.org/article/a6003ae210014e61ae04728c008d1f67
Autor:
Fiorella Calabrese, Federica Pezzuto, Francesca Lunardi, Francesco Fortarezza, Sofia-Eleni Tzorakoleftheraki, Maria Vittoria Resi, Mariaenrica Tiné, Giulia Pasello, Paul Hofman
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 8, p 4164 (2022)
Patients with non-small cell lung cancer, especially adenocarcinomas, harbour at least one oncogenic driver mutation that can potentially be a target for therapy. Treatments of these oncogene-addicted tumours, such as the use of tyrosine kinase inhib
Externí odkaz:
https://doaj.org/article/0d250f452a6e456e8ccf22c931a1ff74
Autor:
Giuditta Galante, Maura Pugliatti, Luisa Caniatti, Eleonora Baldi, Paolo Perri, Giuseppe Lamberti, Massimiliano Castellazzi, Maria Vittoria Resi
Publikováno v:
Disease Markers
Disease Markers, Vol 2019 (2019)
Disease Markers, Vol 2019 (2019)
Background. Multiple sclerosis (MS), a chronic inflammatory and degenerative disease of the central nervous system, typically features immune-mediated focal demyelination and secondary axonal degeneration. Cerebral hypoperfusion of the normal-appeari